Evaluation of neuromuscular effects and antagonism of rocuronium bromide: a preliminary report

Eur J Anaesthesiol Suppl. 1995 Sep:11:65-8.

Abstract

Twenty ASA I-II patients received either 2 or 3 x ED95 doses of rocuronium bromide during nitrous oxide, oxygen, propofol, fentanyl-based anaesthesia. The mean times to maximum block were 98 s and 74 s and the mean duration of clinical relaxation (recovery to 25% T1) was 35 min and 46 min following 620 micrograms kg-1 and 930 micrograms kg-1, respectively. Neuromuscular blockade was antagonized with either neostigmine or edrophonium from a twitch height of 25%. Although there was no significant difference between the recovery times neostigmine appeared to give more consistent antagonism of rocuronium-induced blockade.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Androstanols / administration & dosage
  • Androstanols / antagonists & inhibitors
  • Androstanols / pharmacology*
  • Anesthesia
  • Cholinesterase Inhibitors / pharmacology
  • Double-Blind Method
  • Edrophonium / pharmacology
  • Humans
  • Middle Aged
  • Muscle Relaxation / drug effects
  • Neostigmine / pharmacology
  • Neuromuscular Nondepolarizing Agents / administration & dosage
  • Neuromuscular Nondepolarizing Agents / antagonists & inhibitors
  • Neuromuscular Nondepolarizing Agents / pharmacology*
  • Rocuronium
  • Time Factors

Substances

  • Androstanols
  • Cholinesterase Inhibitors
  • Neuromuscular Nondepolarizing Agents
  • Neostigmine
  • Edrophonium
  • Rocuronium